K GARY BARNETTE
CIK 1314913 · Chief Scientific Officer · last filed 2026-05-06
K GARY BARNETTE is a Chief Scientific Officer who has filed 17 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for VERU, was dated May 6, 2026. Across all open-market trades the lifetime net is −$911.7K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $15.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$15.0K
2
17
-$911.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VERU | Chief Scientific Officer | 5,000 | $3.00 | $15.0K | -$911.7K | 15 | 2026-05-06 |
| Oncternal Therapeutics, Inc. (GTXI) Delisted | Vice President | — | — | — | $0 | 2 | 2008-01-02 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-06 | VERU | Grant (A) | — | $0 | EDGAR |
| 2025-12-09 | VERU | Grant (A) | — | $0 | EDGAR |
| 2025-05-08 | VERU | Grant (A) | — | $0 | EDGAR |
| 2024-05-24 | VERU | Buy (P) | +5,000 | $6.7K | EDGAR |
| 2024-05-09 | VERU | Grant (A) | — | $0 | EDGAR |
| 2023-05-11 | VERU | Grant (A) | — | $0 | EDGAR |
| 2022-11-04 | VERU | Grant (A) | — | $0 | EDGAR |
| 2022-04-25 | VERU | Grant (A) | — | $0 | EDGAR |
| 2021-11-05 | VERU | Grant (A) | — | $0 | EDGAR |
| 2020-12-18 | VERU | Sell (S) | −100,000 | -$1.06M | EDGAR |